Gianluca Del Conte

Phase I study of olaparib in combination with liposomal doxorubicin in patients with advanced solid tumours

Gianluca Del Conte, Cristiana Sessa, Roger von Moos et al. · British Journal of Cancer · 2014 · 102 citations · Full text

A Multi-Arm Phase I Study of the PI3K/mTOR Inhibitors PF-04691502 and Gedatolisib (PF-05212384) plus Irinotecan or the MEK Inhibitor PD-0325901 in Advanced Cancer

Zev A. Wainberg, María Alsina, Heloisa P. Soares et al. · Targeted Oncology · 2017 · 94 citations · Full text

A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer

Stan B. Kaye, Christopher Poole, Anna Dańska-Bidzińska et al. · Annals of Oncology · 2012 · 83 citations

Carboplatin-based Chemotherapy, Medicine, Metronomic Therapy +7

A phase Ib dose-escalation study of the MEK inhibitor trametinib in combination with the PI3K/mTOR inhibitor GSK2126458 in patients with advanced solid tumors

Juneko E. Grilley‐Olson, Philippe L. Bédard, Angelica Fasolo et al. · Investigational New Drugs · 2016 · 80 citations · Full text

Medicine, Metronomic Therapy, Pharmacology +7

Patient Selection for Oncology Phase I Trials: A Multi-Institutional Study of Prognostic Factors

David Olmos, Roger A’Hern, Silvia Marsoni et al. · Journal of Clinical Oncology · 2012 · 79 citations · Full text